The recognition of 25-hydroxyvitamin D2 and D3 by a new binding protein based 25-hydroxyvitamin D assay

Clinica Chimica Acta

Volumn 417, Issue , 2013, Pages 62-66

  Su, Zengliu ^a   Slay, Brian R ^a   Carr, Randall ^a   Zhu, Yusheng ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

25 hydroxyvitamin D; Competitive protein binding assay; Liquid chromatography tandem mass spectrometry

Indexed keywords

25 HYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; CALCIFEDIOL; VITAMIN D BINDING PROTEIN;

ACCURACY; ANALYTICAL EQUIPMENT; ANALYTICAL ERROR; ARTICLE; BINDING ASSAY; COMPETITIVE PROTEIN BINDING ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; STUDENT T TEST; VITAMIN BLOOD LEVEL;

25-HYDROXYVITAMIN D 2; BINDING, COMPETITIVE; BLOOD CHEMICAL ANALYSIS; CALCIFEDIOL; HUMANS; PROTEIN BINDING; VITAMIN D-BINDING PROTEIN;

EID: 84872407186     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.12.018     Document Type: Article

References (22)

1. Matsuo K., Mukai T., Suzuki S., Fujieda K. Prevalence and risk factors of vitamin D deficiency rickets in Hokkaido, Japan. Pediatr Int 2009, 51:559-562.
2. Lips P., Hosking D., Lippuner K., et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 2006, 260:245-254.
3. Sun Q., Shi L., Rimm E.B., et al. Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr 2011, 94:534-542.
4. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004, 79:362-371.
5. Houghton L.A., Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006, 84:694-697.
6. Holick M.F. Vitamin D, status: measurement, interpretation, and clinical application. Ann Epidemiol 2009, 19:73-78.
7. Wallace A.M., Gibson S., de la Hunty A., Lamberg-Allardt C., Ashwell M. Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids 2010, 75:477-488.
8. Hollis B.W. Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Endocrinol Metab Clin North Am 2010, 39:271-286.
9. Stepman H.C., Vanderroost A., Van Uytfanghe K., Thienpont L.M. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 2011, 57:441-448.
10. Tai S.S., Bedner M., Phinney K.W. Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem 2010, 82:1942-1948.
11. Roth H.J., Schmidt-Gayk H., Weber H., Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 2008, 45:153-159.
12. Glendenning P., Taranto M., Noble J.M., et al. Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Ann Clin Biochem 2006, 43:23-30.
13. Annesley T.M. Ion suppression in mass spectrometry. Clin Chem 2003, 49:1041-1044.
14. Bouillon R., Van Herck E., Jans I., Tan B.K., Van Baelen H., De Moor P. Two direct (nonchromatographic) assays for 25-hydroxyvitamin D. Clin Chem 1984, 30:1731-1736.
15. Product insert, Nichols ADVANTAGE 25-hydroxyvitamin Dassay 2004, Nichols Institute Diagnostics, San Juan Capistrano, CA.
16. Carter G.D., Berry J.L., Gunter E., et al. Proficiency testing of 25-hydroxyvitamin D (25-OHD) assays. J Steroid Biochem Mol Biol 2010, 121:176-179.
17. Hollis B.W. Editorial: the determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab 2004, 89:3149-3151.
18. Sempos C.T., Vesper H.W., Phinney K.W., Thienpont L.M., Coates P.M. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl 2012, 243:32-40.
19. Carter G.D., Carter R., Jones J., Berry J. How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 2004, 50:2195-2197.
20. Horst R.L., Reinhardt T.A., Beitz D.C., Littledike E.T. A sensitive competitive protein binding assay for vitamin D in plasma. Steroids 1981, 37:581-591.
21. Singh R.J., Taylor R.L., Reddy G.S., Grebe S.K. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006, 91:3055-3061.
22. Lensmeyer G., Poquette M., Wiebe D., Binkley N. The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J Clin Endocrinol Metab 2012, 97:163-168.